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The prognosis of primary angiosarcoma of the pulmonary
system is generally poor, irrespective of whether the location is in
the pulmonary parenchyma or the main airway. Angiosarcoma of
the pulmonary parenchyma is invariably fatal within months be-
cause metastases are usually present at the time of detection, and
chemotherapy thus far has not proved effective. The clinical course
of solitary angiosarcoma of the main airway is also dismal in
previous reports.2,4 However, mortality of these patients was
mainly caused by massive and intractable hemoptysis of the small
resectable tumor rather than by the invasiveness of the disease.
From the experience of successful treatment of this patient, angio-
sarcoma should be considered in the differential diagnosis of a
primary tracheal tumor. Furthermore, prompt surgical intervention
with adequate resection margins is recommended in the manage-
ment of these patients when the disease is localized at detection.
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Primary choriocarcinoma of the lung
Anna Arslanian, MD,a Franco Pischedda, MD,a Pier Luigi Filosso, MD,a Paolo Di Marzio, MD,a Alberto Oliaro, MD,a
Flavio Fraire, MD,b and Mauro Papotti, MD,b Torino, Italy
Choriocarcinoma is a malignant proliferation of theLangerhans cell and of syncytial cells of trophoblasticorigin that is normally situated in the female genitaltract after a gestational event such as molar pregnancy,
term pregnancy, abortion, or ectopic pregnancy.1 Rarely it occurs
in either sex as a midline lesion in the retroperitoneum, mediasti-
num, and the region of the pineal gland. Less frequently it is found
in the bladder, liver, stomach, and colon, where it is seen in
combination with adenocarcinoma.2-4 In men, choriocarcinoma
occurs in the testis in combination with such tumors as seminoma,
teratoma, and embryonal carcinoma.1 The literature contains few
cases of lung localization of choriocarcinoma. The prognosis of
this tumor is extremely poor, despite surgical and chemotherapeu-
tic treatment.5 We report a surgically treated case of choriocarci-
noma in a 37-year-old woman who came to our attention because
of a lung tumor with radiologic characteristics similar to those of
a solitary fibrous tumor of the pleura.
Clinical Summary
During surgical evaluation for cholecystectomy for cholelithiasis
in a 37-year-old woman, the chest radiograph showed an opacity in
the right inferior pulmonary lobe (Figure 1). Computed tomo-
graphic scans demonstrated a well-demarcated mass similar to
solitary fibrous tumor of the pleura (Figure 2). On physical exam-
ination, the woman appeared healthy with stable vital signs. The
patient referred in her history to an operation for vesicular mole
that had occurred 7 years previously.
A needle biopsy was performed, and the result of cytologic
examination of the cells was compatible with the hypothesis of
fibrous tumor. A right thoracotomy was performed. The lung
appeared to be infiltrated by a tumor not compatible with the
hypothesis of a solitary fibrous tumor of the pleura. An inferior
lobectomy was performed. The postoperative recovery was un-
eventful, and the patient was discharged in 8 postoperative days. A
definitive histologic examination demonstrated a choriocarcinoma
(Figure 3, a-e). -Human chorionic gonadotropin (-HCG) was
measured in the serum at that time, and the level was high (597
IU/L, whereas the normal level is 0-10 IU/L).
Computed tomographic scan of the ovary and the genital ap-
paratus was performed to research a possible primary localization,
but nothing was found. Hysteroscopy was also performed, and
results were negative. The previous specimen of the vesicular mole
was reexamined, but no cells of choriocarcinoma were found.
Chemotherapy was started 2 months after thoracic surgery and
consisted of bleomycin, etoposide, and cisplatin. Before the start of
chemotherapy, the level of -HCG was measured; it was 8 U/L 40
days after surgery. At 1-year follow-up the patient is alive in good
condition. The -HCG level is actually normal.
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Discussion
Choriocarcinoma is a germ cell tumor containing syncytiotro-
phoblastic cells and secreting human -HCG.4-6 Primary cho-
riocarcinoma of the lung is extremely uncommon, with roughly
20 cases reported in the literature. In contrast to other extrago-
nadal germ cell tumors, choriocarcinoma appears more fre-
quently in women and elderly men. The origin of these tumors
at this site is unknown, but there are several theories. The
tumors could represent metastases from a primary gonadal
neoplasm undergoing spontaneous regression.1,6 It is also pos-
sible that they are derived from a progression to malignancy of
trophoblastic emboli from a previous vesicular mole, term
pregnancy, abortion, or ectopic pregnancy months or years
before.3,6 Another hypothesis is that there was a differentiation or
metaplasia to trophoblast from a primary lung cancer. Finally, the
tumor could have been generated from remaining germ cells after an
anomalous migration during the embryonic phase.6
Pulmonary choriocarcinoma can appear in different ways. Re-
current hemoptysis seems to be the most frequent symptom; in
addition to this, it has been reported as chest pain, persistent cough,
and signs of feminization in men with gynecomastia, loss of libido,
and testicular atrophy. Distant metastases are commonly present in
the lung, brain, and kidney.3,6
Two typical characteristics of this tumor represent the chorio-
carcinoma syndrome: the bleeding tendency of the primary and
metastatic sites and the constant elevation of serum -HCG lev-
els.6 -HCG is useful for diagnostic, prognostic, and follow-up
purposes.2
A positive -HCG test result in patients with hemoptysis and
progressive dyspnea could be diagnostic for a pulmonary chorio-
carcinoma and may be helpful for a early diagnosis.5,6 The diag-
nostic criteria would include lack of a previous gynecologic ma-
lignancy, solitary or predominant lung lesion with the exclusion of
a gonadal primary site, raised serum -HCG titers that become
normal after surgery or chemotherapy, and pathologic confirma-
tion of the disease.
Hematologic analysis shows also leukocytosis with neutro-
philia and elevated sedimentation rate.5 Although urinary -HCG
has considerable diagnostic and prognostic value, a negative test
result does not exclude presence of these neoplasms.
The radiologic presentation may be nodular image, diffuse
shadowing, or miliary or micronodular forms with or without
interstitial infiltrates.5 Diagnosis is often delayed, and pleural
effusion may be present.
Bronchoscopic examination yields negative results for this
tumor.5 Percutaneous needle biopsy often shows a largely ne-
crotic nonBsmall cell carcinoma interpreted as squamous cell
type from the deeply eosinophilic cytoplasm, suggesting kera-
tinization in the few viable anaplastic cells. Electron micro-
scopic features of tonofilaments are present on ultrastructural
analysis, also in keeping with squamous differentiation. Immu-
nohistochemical staining shows cytotrophoblastic cells reactive
for -HCG. Coexistence with adenocarcinoma of the lung has
been reported in the literature.1,3
The surgical option is often selected on the basis of pre-
sumed squamous cell carcinoma of the lung in the absence of
distant and regional metastases, and the correct diagnoses rep-
resent a surprise at histologic diagnosis.2 So, as in this case,
-HCG was not measured before surgery. The natural course of
choriocarcinoma is rapidly fatal in the great majority of cases.5
We think that surgical excision according to the oncologic
criteria for bronchopulmonary cancer is advisable, however,
because there are no established therapeutic guidelines and this
tumor evolved rapidly with bleeding, chest pain, and dyspnea.
More or less 30 days after surgery, the -HCG level returned to
normal. During follow-up an elevation of -HCG would be
indicative of micrometastasis.2
Chemotherapy is indicated for this tumor independently of
surgery and consists of bleomycin, etoposide, and cisplatin.2 Non-
gestational choriocarcinoma, unlike that arising from a gestational
tumor, is unresponsive to irradiation. The reason is unknown.1
Figure 1. Chest radiograph showing right lower lung mass.
Figure 2. Computed tomographic scan confirming image of well-
delimited mass in lung.
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Frequent Signs and Symptoms
General syndrome.
● Significant deterioration of the patient’s health is seen, as in
cancer.
● There is scanty but recurrent hemoptysis.
● Patient reports chest pain.
● Patient has a dry, persistent cough
● Signs of feminization are present in men, with gynecomastia,
loss of libido, and testicular atrophy.
Radiologic evidence. Appearance of the tumor may be diffuse
or defined.
Hematologic analysis. Positive results are seen on -HCG
test. Leukocytosis is present, with neutrophilia and elevated sedi-
mentation rate.
Urinalysis. -HCG may be present in the urine.
Figure 3. a, Neoplastic giant cells at lung parenchyma (hematoxylin-eosin, original magnification 200). b,
Immunohistochemical staining for -HCG: evidence of positivity of neoplastic giant cells (original magnification
200). c and d, Detail of choriocarcinoma: observation of pathologic plurinucleate giant cells (hematoxylin-eosin,
original magnification400). e, Immunohistochemical staining for -HCG: nidi of cells positive for -HCG (original
magnification 400).
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Brucella melitensis endocarditis of ventricular septal defect patch:
Successful surgical treatment without replacement
Ugursay Kiziltepe, MD,a Adnan Uysalel, MD,a Ercan Tutar, MD,b and Hakki Akalin, MD,a Ankara, Turkey
Brucella melitensis endocarditis is a rare but fatal com-plication of brucellosis. It is usually located on nativeand prosthetic valves.1 Endocarditis of a prostheticventricular septal defect (VSD) patch is rare. Only one
case of treatment by means of replacement of the prosthetic patch
and antibiotic administration has been reported.2 When present,
removal and replacement of the infected tissue or prosthetic ma-
terial has been recommended in addition to long-term antibiotic
treatment to achieve a cure.3,4 Replacement of the prosthetic patch
might not always be necessary, as was the case in our experience.
Clinical Summary
A 12-year-old boy with cyanosis and growth retardation was given
a diagnosis of tetralogy of Fallot. He underwent a successful total
correction operation with Dacron patch repair of a VSD with
interrupted pledgeted sutures and transannular Dacron patch right
ventricular outflow tract reconstruction. The early postoperative
period was uneventful, and no residual VSD was found at early
postoperative echocardiography. He was discharged to home, but
2 weeks later, he was readmitted to the hospital with fever and
arthralgia. The initial echocardiography revealed a very small hole
at the edge of the VSD patch and no apparent vegetation. At that
time, blood cultures did not show growth of any microorganism.
Wide-spectrum antibiotics and antipyretic treatment were started.
The erythrocyte sedimentation rate was 95 mm/h, and the C-reac-
tive protein level was 3. After 1 week, his general status had
worsened, and symptoms of congestive heart failure and a harsh
pansystolic murmur had appeared. Repeat echocardiography
showed the presence of a large recurrent VSD but no visible
vegetation (Figure 1). Cardiac catheterization revealed a pulmo-
nary/systemic flow ratio of 2.2 and a pulmonary artery pressure of
45 mm Hg. His culture results were still negative. He received
vancomycin and amikacin treatments for 10 days before surgical
repair. During reoperation, a large hole and extensive vegetation
were found at the muscular septal edge of the prosthetic patch. The
pledget-supported sutures were pulled off through the torn myo-
cardium. Because the general status of the patient was poor and he
might not tolerate long crossclamp and cardiopulmonary bypass
(CPB) periods and because the presence of B melitensis endocar-
ditis was not known at this stage, we decided to perform extensive
debridement of the vegetation and reattachment of the same patch
to the septum instead of resection and replacement of the pros-
thetic patch. After reattachment of the patch with 4 pledgeted
sutures, the heart was deaired, and the crossclamp was removed.
After rewarming, the patient was easily weaned from CPB. Cross-
clamp and CPB times were 46 and 71 minutes, respectively. The
postoperative period was uneventful. Vancomycin and amikacin
treatments were continued for another 10 days. After the cultures
from the debrided tissue and blood revealed B melitensis endocar-
ditis, those antibiotics were replaced with 200 mg/d doxycycline
and 600 mg/d rifampin (INN: rifampicin), which were continued
for 4 months. No complications were seen during the postoperative
period. After antibiotic treatment was completed, the patient was
totally symptom free. He has completed his second postoperative
year without additional antibiotic treatment, and his blood culture
and serologic test results are negative. His most recent echocardi-
ography at 24 months postoperatively showed an intact VSD patch
without vegetation or residual VSD. He is considered to be totally
cured.
Comment
Brucellosis is seen more frequently in Mediterranean, Arabic pen-
insula, Indian subcontinent, and South-Central American regions.
It is a zoonosis and is transmitted to human patients by means of
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